Quantitative analysis of bioluminescence flux confirmed these findings, demonstrating the most tumor cell death in the iMRAS conjugated with CD1d/αGC+IL-15Tx group (Fig. 2d, e). The gene discussed is CD1D; the disease is neoplasm.